Partner David Rosen provides an overview of the Food and Drug Administration’s increasing use of consent decrees as compliance enforcement tools, stating that companies can potentially improve their manufacturing operations and systems quality by efficiently meeting the terms and conditions of a consent decree. He adds that entering into a consent decree requires significant time and resources, but notes that companies can better meet these requirements by proactively investing in a comprehensive quality program.
Click here to read the complete article.
Author(s)
Related Insights
20 May 2024
Events
Lunch & Learn – An AI Conversation
Join the Utah Tech Community for a lunch & learn exploring the evolution of AI and its implications for founders and finance teams.
23 April 2024
Article
The Rubber Meets the Road on State and Federal Vehicle Emissions Strategies
March and April have been busy months for vehicle emission regulation in the U.S. On March 20 and March 29 respectively, the U.S. Environmental Protection Agency issued a set of final emission rules setting stringent emission standards for all vehicle classes.
09 May 2024
Events
The Changing Hospital Landscape
Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, is moderating a panel at the 2024 Convergence Forum titled “The Changing Hospital Landscape.”